- Tytuł:
- Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin‐4‐IgG4‐Fc in healthy subjects: A phase 1, single‐centre, randomized, double‐blind, dose escalation study.
- Autorzy:
- Temat:
-
GLUCAGON-like peptide-1 receptor
IMMUNE response
TYPE 2 diabetes
GLUCOSE tolerance tests
PHARMACOKINETICS - Źródło:
- Diabetes, Obesity & Metabolism; Apr2024, Vol. 26 Issue 4, p1395-1406, 12p
Czasopismo naukowe